Sana Biotechnology Inc (SANA)
Healthcare
Biotechnology
—
3.20 $
+1.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Sana Biotechnology Inc (SANA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -37 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -59 | -64 | -52 | -66 | -59 | -52 | -47 | -49 | -33 | -29 | -33 | -37 | -133 | |
| 4.4 | 4.5 | 7.5 | 3.7 | 3.9 | 4.1 | 5.7 | 3.6 | 2.9 | 3.2 | 3.1 | 2.4 | 11 | |
| 9.8 | 9.0 | 7.9 | 9.1 | 11 | 11 | 6.4 | 7.0 | 6.6 | 5.5 | 6.3 | 5.7 | 24 | |
| 37 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 14 | 5.2 | 10 | -7.5 | 2.3 | -0.3 | 4.3 | -11 | -3.4 | 0.7 | 3.4 | -6.5 | -5.8 | |
| 1.6 | 2.2 | 14 | 16 | 13 | 4.1 | 0.4 | 0.1 | 0.1 | 0.0 | 0.9 | 0.3 | 1.3 | |
| 43 | 51 | 15 | -77 | 5.8 | 42 | 47 | 17 | 7.7 | -48 | -16 | 49 | -7.4 | |
| – | – | – | – | – | – | – | -0.1 | 0.1 | – | -0.1 | – | – | |
| – | – | – | – | – | – | – | -0.1 | – | – | – | -0.1 | – | |
| 30 | 0.2 | 1.7 | 186 | 11 | 2.1 | 0.6 | 1.0 | 0.6 | 110 | 18 | -0.1 | 128 | |
| 13 | -12 | -35 | 44 | -42 | -8.0 | 0.6 | -31 | -25 | 32 | -31 | 12 | -12 | |
| -60 | -66 | -66 | -81 | -72 | -56 | -48 | -49 | -33 | -29 | -34 | -38 | -134 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.